Norepinephrine is used to treat severe low blood pressure, typically in hospital settings when other treatments haven't worked. It works by narrowing blood vessels and strengthening the heart's contractions to increase blood pressure.[1] Levophed is currently being investigated across 20 indications[3], with its most advanced program in Phase 3.[1]
Levophed is one of 439 small molecule programs targeting Cataract. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
146 competitors in Cardiovascular Disease
Levophed
Avandia
Inspra
Adrenaline
Tekturna
Trental
Catapres
Caverject
Colcrys
Pelacarsen
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Breast Reconstruction
NCT06080178
Vascular Dysfunction
NCT01426529
Intraoperative Hypotension
NCT07627360
Hot Flashes
NCT05193968
Acute Kidney Injury
NCT07418541
Intensive Care Unit
NCT02118467
Clinical
Sources
Details